Description
Tirzepatide (GLP-2 TZ) (10 mg) is supplied as a lyophilized powder in a Type I borosilicate glass vial sealed under vacuum. Tirzepatide is a lyophilized dual-agonist research peptide studied in-vitro for its activity at GLP-1 and GIP receptors.
Molecular formula C₂₂₅H₃₄₈N₄₈O₆₈, molecular weight 4,813.5 g/mol, sequence length 39 amino acids (CAS 2023788-19-2).
Every production lot is synthesized in a validated cGMP-grade research facility and independently assayed by accredited third-party analytical laboratories using reverse-phase HPLC and mass spectrometry. Each vial is verified to ≥99.0% purity and shipped with a certificate of analysis tied to the unique vial code printed on the label.
Research Use Only. This product is sold strictly as a research chemical for in-vitro laboratory study by qualified researchers and institutional laboratories. Not for human consumption, therapeutic use, or administration of any kind. Not a drug, food, cosmetic, or dietary supplement.




